Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

PE Firms Flipping Drugs

Private equity firms take advantage of soaring drug prices to capitalize on short-term acquisitions.

Drug-Flipping is relatively low-risk / Photo: FiercePharma
Drug-Flipping is relatively low-risk / Photo: FiercePharma

A recent Bloomberg article explained how dealmakers are treating aging drugs like companies and flipping them. The model is perfectly legal and equally simple: acquire licensing rights, raise the price, and put the licensing back on the market at a hefty premium. Private equity firms are attracted to what some are calling “financial engineering,” because it’s relatively low-risk with a speedy payout.

Consider Actimmune, which Genentech sold to a private equity firm in 2012 for $55 million. The firm raised the drug’s price 434% before selling it to Horizon Pharma for $660 million just two years later. According to data from Connecture, about 650 branded drugs doubled between 2011 and 2015, and 100 of them raised prices 500% or more.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences